STUDY OF B CELL GROWTH BY EPSTEIN BARR VIRUS
爱泼斯坦巴尔病毒对 B 细胞生长的研究
基本信息
- 批准号:3811215
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Epstein-Barr virus (EBV) infects human B cells and induces their
immortalization. The molecular basis for EBV immortalization is largely
unknown. Recently, it was observed that when EBV immortalized cells are
cultured without serum at critically low densities, proliferation ceases
and the cells die. However, addition of cell-free supernatants
from-exponentially growing EBV-immortalized cell lines can rescue these
cells from death and promote their proliferation. Recently, we have
identified IL-6 as being one of the autocrine growth factors for
EBV-immortalized B cells (Tosato, G. et al, J. Virol., 1990) However, only
approximately 25% of autocrine growth factor activity is attributable to
IL-6 while the remaining autocrine growth factor activity resides in a low
molecular weight component. The goal of the present study is to identify
the molecule or molecules responsible for this low molecular weight
autocrine growth factor. So far, we have gathered a great deal of
information but have not as yet identified the structure of this low
molecular weight growth@factor activity. We have determined that its
relative molecular weight is greater than 200 and smaller than 500. We have
also determined that it is not a peptide because treatments designed to
destroy the peptide bond fail to reduce its biological activity.
Purification of the low molecular weight autocrine growth factor is
underway and a number of steps have been identified, including size
fractionation, anion exchange chromatography and counter current
electrophores. Future efforts will concentrate on further purifying the
molecule from contaminants and determining its structure.
eb病毒(EBV)感染人类B细胞并诱导其凋亡
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
G TOSATO其他文献
G TOSATO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('G TOSATO', 18)}}的其他基金
INTERLEUKIN-10 INHIBITS T CELL PROLIFERATION AND INTERFERON GAMMA PRODUCTION
INTERLEUKIN-10 抑制 T 细胞增殖和干扰素 GAMMA 产生
- 批准号:
3804773 - 财政年份:
- 资助金额:
-- - 项目类别:
INTERLEUKIN 6 SERUM LEVELS IN SOLID ORGAN TRANSPLANT RECIPIENTS
实体器官移植受者的白细胞介素 6 血清水平
- 批准号:
3792501 - 财政年份:
- 资助金额:
-- - 项目类别:
ROLE OF GROWTH FACTORS IN EBV-POSITIVE POST-TRANSPLANT L
生长因子在 EBV 阳性移植后 L 中的作用
- 批准号:
6161313 - 财政年份:
- 资助金额:
-- - 项目类别:
IL12, IP10, AND IL15 ARE POTENT REGULATORS OF ANGIOGENE
IL12、IP10 和 IL15 是血管生成的有效调节剂
- 批准号:
6161314 - 财政年份:
- 资助金额:
-- - 项目类别:
IL-2 AND IP-10 ARE POTENT REGULATORS OF ANGIOGENESIS
IL-2 和 IP-10 是血管生成的有效调节剂
- 批准号:
2456635 - 财政年份:
- 资助金额:
-- - 项目类别:
A ROLE FOR INTERLEUKIN-6 IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
INTERLEUKIN-6 在移植后淋巴细胞增殖性疾病中的作用
- 批准号:
3748223 - 财政年份:
- 资助金额:
-- - 项目类别:
PRECLINICAL MODELS FOR TESTING OF BIOLOGICAL CANCER THERAPEUTICS
用于测试生物癌症治疗的临床前模型
- 批准号:
6161318 - 财政年份:
- 资助金额:
-- - 项目类别:
A ROLE FOR INTERLEUKIN-6 IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
INTERLEUKIN-6 在移植后淋巴细胞增殖性疾病中的作用
- 批准号:
5200781 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus
项目 4 - 控制 Epstein-Barr 病毒中的潜伏至裂解转换
- 批准号:
10910338 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Epstein-Barr Virus nuclear antigen leader protein in transcription regulation
Epstein-Barr病毒核抗原前导蛋白在转录调控中的作用
- 批准号:
10829620 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
- 批准号:
10889325 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
了解器官移植后儿童淋巴瘤发展之前针对 Epstein-Barr 病毒感染的临床干预的免疫反应变化(UNEARTH)
- 批准号:
10755205 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Regulation and Functions of the Epstein-Barr Virus Lytic Switch Protein
EB 病毒裂解开关蛋白的调控和功能
- 批准号:
489085 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway
Epstein-Barr 病毒颠覆宿主 SMC5/6 限制途径的特征
- 批准号:
10679118 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease
EB 病毒驱动的移植后淋巴增殖性疾病的机制
- 批准号:
10755055 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
解读 Epstein-Barr 病毒分子拟态和 B 细胞转化在多发性硬化症中的作用
- 批准号:
10568864 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe
项目 2:对 Epstein-Barr 病毒作为津巴布韦艾滋病毒感染者结膜鳞状细胞癌潜在原因的新调查
- 批准号:
10598376 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Project 3 - Characterizing the Amplification Factories of Epstein-Barr Virus and Kaposi's Sarcoma-associated Herpesvirus
项目 3 - 描述 Epstein-Barr 病毒和卡波西肉瘤相关疱疹病毒的扩增工厂
- 批准号:
10910337 - 财政年份:2023
- 资助金额:
-- - 项目类别:














{{item.name}}会员




